NNCSF (Nanosonics) LT-Debt-to-Total-Asset: 0.01 (As of Dec. 2025)

What is Nanosonics LT-Debt-to-Total-Asset?

Nanosonics NNCSF 90 LT-Debt-to-Total-Asset is 0.01 as of Dec. 2025. GuruFocus rates NNCSF with a GF Score™ of 90/100 and a GF Value™ of $3.58 (Modestly Undervalued). The stock has 1 warning sign investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Nanosonics's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.01.

Nanosonics's long-term debt to total assets ratio declined from Dec. 2024 (0.02) to Dec. 2025 (0.01). It may suggest that Nanosonics is progressively becoming less dependent on debt to grow their business.

Nanosonics (OTCPK:NNCSF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Nanosonics LT-Debt-to-Total-Asset Related Terms

Nanosonics LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Nanosonics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanosonics LT-Debt-to-Total-Asset Chart

Nanosonics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.05

0.04

0.03

0.02

Nanosonics Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.03	0.02	0.02	0.01

90GF Score

Nanosonics Ltd NNCSF

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nanosonics LT-Debt-to-Total-Asset Calculation

Nanosonics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as

LT Debt to Total Assets (A: Jun. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2025 )	/	Total Assets (A: Jun. 2025 )
	=	2.775	/	177.397
	=	0.02

Nanosonics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	2.131	/	185.551
	=	0.01

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.01 mean?

Nanosonics (NNCSF) has a LT-Debt-to-Total-Asset of 0.01 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Nanosonics and its competitors.

Is Nanosonics' LT-Debt-to-Total-Asset too high?

Nanosonics' current LT-Debt-to-Total-Asset is 0.01. Overall, Nanosonics has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Nanosonics' LT-Debt-to-Total-Asset compare to ISRG and BDX?

Nanosonics' LT-Debt-to-Total-Asset of 0.01 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Nanosonics and its competitors. Nanosonics's current LT-Debt-to-Total-Asset is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nanosonics stock overvalued right now?

Based on GuruFocus' analysis, Nanosonics (NNCSF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.58, compared to a current price of $2.55 — trading 28.8% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.01. Nanosonics' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Nanosonics (NNCSF), the current LT-Debt-to-Total-Asset is 0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanosonics (NNCSF) Overvalued in 2026?

Based on GuruFocus' analysis, Nanosonics stock appears to be undervalued. The current stock price of $2.55 is trading 28.8% below its estimated GF Value™ of $3.58. GuruFocus considers Nanosonics to be Modestly Undervalued.

Key valuation signals for NNCSF:

LT-Debt-to-Total-Asset: 0.01
GF Value™: $3.58 vs. price of $2.55 (28.8% below fair value)
GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the NNCSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanosonics Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies ASX:SDI ASX:AHC ASX:TRJ ASX:OSX ASX:ANN ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM XSWX:STMN XTER:SRT OCSE:COLO B NZSE:FPH SOLV

Other Exchanges NAN:Australia

Address 7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113

Website https://www.nanosonics.com.au

Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.

90GF Score

Get the complete analysis for NNCSF

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.55

Price

$3.58

GF Value

View NNCSF Analysis

See LT-Debt-to-Total-Asset data for all stocks →